Inventory decreased 28.7%
Inventory changed -28.7% from the comparable as-filed period.
$12.1M→$8.7M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →EVLV financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 1097 bp higher
Working capital / assets changed +1097 basis points from the comparable as-filed period.
-3.50%→7.47%2 prior comparisons
Operating cash-flow margin moved 2071 bp higher
Operating cash-flow margin changed +2071 basis points from the comparable as-filed period.
6.49%→27.20%3 prior comparisons
Receivables / revenue moved 3800 bp lower
Receivables / revenue changed -3800 basis points from the comparable as-filed period.
128.45%→90.45%1 prior comparisons
Current liabilities decreased 11.2%
Current liabilities changed -11.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$142.9M→$126.8M2 prior comparisons
Current assets increased 12.3%
Current assets changed +12.3% from the comparable as-filed period.
$133.1M→$149.4M2 prior comparisons
SBC / revenue moved 138 bp lower
SBC / revenue changed -138 basis points from the comparable as-filed period.
17.04%→15.66%3 prior comparisons
Current ratio increased 26.5%
Current ratio changed +26.5% from the comparable as-filed period.
0.93→1.182 prior comparisons
Stock-based compensation increased 23.5%
Stock-based compensation changed +23.5% from the comparable as-filed period.
$5.5M→$6.9M3 prior comparisons
Working capital changed across a sign change
Working capital changed +330.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$9.8M→$22.6M2 prior comparisons
Total assets increased 7.7%
Total assets changed +7.7% from the comparable as-filed period.
$280.4M→$302.0M2 prior comparisons
Gross margin moved 34 bp higher
Gross margin changed +34 basis points from the comparable as-filed period.
49.83%→50.17%3 prior comparisons
Shares outstanding increased 5.4%
Shares outstanding changed +5.4% from the comparable as-filed period. The change ranks at the 60th percentile of 5 prior comparable changes.
171,891,467→181,126,1465 prior comparisons
Trade receivables decreased 5.3%
Trade receivables changed -5.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$41.8M→$39.6M2 prior comparisons
R&D / revenue moved 134 bp lower
R&D / revenue changed -134 basis points from the comparable as-filed period.
14.56%→13.21%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.